Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
Thrombosis Research|March 8, 2013
Expert-opinion on non-inferiority margin: a case study of oral anti-coagulant agents for prophylaxis of venous thromboembolic events after orthopedic surgeryGrace Wangge, Anthonius de Boer, Olaf H Klungel, et al.
Pharmacogenomics|September 17, 2011
Implementation of pharmacogenetics in clinical practice is challengingRianne M F van Schie, Anthonius de Boer, Anke Hilse Maitland-van der Zee
Pharmacoepidemiology and Drug Safety|August 16, 2021
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impactMirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes: Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS)Boris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Journal of Clinical Epidemiology|December 20, 2005
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculationBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Plos One|September 27, 2014
Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines listsYaser T Bazargani, Anthonius de Boer, Hubert G M Leufkens, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 19, 2010
Insomnia medication: do published studies reflect the complete picture of efficacy and safety?Taina Mattila, Violeta Stoyanova, André Elferink, et al.
Clinical Therapeutics|December 22, 2005
Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysisMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 18, 2021
Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based studyTalip E Eroglu, Marieke T Blom, Patrick C Souverein, et al.
Heart (British Cardiac Society)|May 16, 2007
Effect of drug combinations on admission for recurrent myocardial infarctionMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
Thrombosis Research|March 8, 2013
Expert-opinion on non-inferiority margin: a case study of oral anti-coagulant agents for prophylaxis of venous thromboembolic events after orthopedic surgeryGrace Wangge, Anthonius de Boer, Olaf H Klungel, et al.
Pharmacogenomics|September 17, 2011
Implementation of pharmacogenetics in clinical practice is challengingRianne M F van Schie, Anthonius de Boer, Anke Hilse Maitland-van der Zee
Pharmacoepidemiology and Drug Safety|August 16, 2021
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impactMirjam Hempenius, Rolf H H Groenwold, Anthonius de Boer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
A comparison of two multiple-characteristic decision-making models for the comparison of antihypertensive drug classes: Simple Additive Weighting (SAW) and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS)Boris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Journal of Clinical Epidemiology|December 20, 2005
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculationBoris L G Van Wijk, Olaf H Klungel, Eibert R Heerdink, et al.
Plos One|September 27, 2014
Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines listsYaser T Bazargani, Anthonius de Boer, Hubert G M Leufkens, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 19, 2010
Insomnia medication: do published studies reflect the complete picture of efficacy and safety?Taina Mattila, Violeta Stoyanova, André Elferink, et al.
Clinical Therapeutics|December 22, 2005
Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysisMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 18, 2021
Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based studyTalip E Eroglu, Marieke T Blom, Patrick C Souverein, et al.
Heart (British Cardiac Society)|May 16, 2007
Effect of drug combinations on admission for recurrent myocardial infarctionMenno E van der Elst, Marcel L Bouvy, Cornelis J de Blaey, et al.
Pageof 31